Bixiye
QP44-17 New Pre-Authorization Form for Botulinum Toxin for Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: Des 05, 2017
Natiijooyinka Raadinta
Soo bandhiga 3031 - 3040 ee natiijooyinka 4130
Bixiye
QP12-17 Prior Authorization/Pre-Approval Forms Specific to Select Medical Policies
Taariikhda uu dhaqangalayo Barnaamijka: May 31, 2017
Bixiye
QP32-16 Centurion Contracts with BlueLink TPA for Claims Administration Servicesa
Taariikhda uu dhaqangalayo Barnaamijka: Nov 18, 2016
Bixiye
P59-16 Organization Determination Additions for Platinum Blue - Effective January 23, 2017
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2016
Bixiye
P51-16 Addition of a Drug (Belviq XR) to the Weight Loss Agents Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2016
Bixiye
P19R2-18 Update: New Remittance Code OA-45/N801 for Purchased/Referred Care (PRC) - Eligible Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P26-17 New Drug-Related Prior Authorization (PA) Criteria: Urea Cycle Disorders
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P54-16 Added Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2016
Bixiye
P18-17 New Drug-Related Prior Authorization Requirements for Nusinersen (Spinraza)
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2017
Bixiye
P59-18 New Acupuncture Update for Commercial Lines of Business - Effective January 1, 2019
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2018